Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Resteghini C, Argiris A, Blanchard P, Braña I, Camarda AM, Chan ATC, Ferris R, Gregoire V, Harrington KJ, Tinhofer I, Koljenović S, Lee NY, Leemans CR, Machiels JP, Mehanna H, Metcalf R, O'Sullivan B, Oosting S, Orlandi E, Paleri V, Psyrri A, Saba NF, Schmitz S, Simon C, Tahara M, Poorten VV, Vošmik M, Bossi P

Open source

DOI: 10.1016/j.ctrv.2026.103175
Published: 2026 Jul
Container: Cancer treatment reviews
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ctrv.2026.103175,
  title = {Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.},
  author = {Resteghini C and Argiris A and Blanchard P and Braña I and Camarda AM and Chan ATC and Ferris R and Gregoire V and Harrington KJ and Tinhofer I and Koljenović S and Lee NY and Leemans CR and Machiels JP and Mehanna H and Metcalf R and O'Sullivan B and Oosting S and Orlandi E and Paleri V and Psyrri A and Saba NF and Schmitz S and Simon C and Tahara M and Poorten VV and Vošmik M and Bossi P},
  year = {2026},
  journal = {Cancer treatment reviews},
  doi = {10.1016/j.ctrv.2026.103175},
  url = {https://doi.org/10.1016/j.ctrv.2026.103175}
}

RIS

TY  - JOUR
TI  - Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.
AU  - Resteghini C
AU  - Argiris A
AU  - Blanchard P
AU  - Braña I
AU  - Camarda AM
AU  - Chan ATC
AU  - Ferris R
AU  - Gregoire V
AU  - Harrington KJ
AU  - Tinhofer I
AU  - Koljenović S
AU  - Lee NY
AU  - Leemans CR
AU  - Machiels JP
AU  - Mehanna H
AU  - Metcalf R
AU  - O'Sullivan B
AU  - Oosting S
AU  - Orlandi E
AU  - Paleri V
AU  - Psyrri A
AU  - Saba NF
AU  - Schmitz S
AU  - Simon C
AU  - Tahara M
AU  - Poorten VV
AU  - Vošmik M
AU  - Bossi P
PY  - 2026
JO  - Cancer treatment reviews
DO  - 10.1016/j.ctrv.2026.103175
UR  - https://doi.org/10.1016/j.ctrv.2026.103175
ER  -

APA

C, R., A, A., P, B., I, B., AM, C., ATC, C., R, F., V, G., KJ, H., I, T., S, K., NY, L., CR, L., JP, M., H, M., R, M., B, O., S, O., E, O., V, P., A, P., NF, S., S, S., C, S., M, T., VV, P., M, V., & P, B. (2026). Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.. Cancer treatment reviews. https://doi.org/10.1016/j.ctrv.2026.103175

Source records

pubmed · retrieved 2026-09-26T01:13:28.874Z